Home | Archives | Products | About | Contact | FAQ |
New User? Sign Up | Sign In
insider trading reports Form 4 Filings Insider Buys Significant Buys Penny Stocks
Insider Buying
Insider Sales
Insider Buy Sell Ratios Stock Options Insider Trading
Stock Screener
Insider Trading
Graph View
Insider Watch

Insider Trading - Aprea Therapeutics Inc. (APRE)

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
APRE Insider Trading Transactions for Aprea Therapeutics Inc.

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2019-10-07
Purchase
2019-10-09
6:23 pm
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
DIEKMAN JOHN D
Schwab Andrew J.
PARMAR KUSH
10% Owner
333,333 $15 $4,999,995 2,418,548
(Indirect)
View
2019-10-07
Purchase
2019-10-08
8:13 pm
Aprea Therapeutics Inc. APRE Redmile Group LLC
Green Jeremy
10% Owner
400,000 $15 $6,000,000 2,268,718
(Indirect)
View
2019-10-07
Purchase
2019-10-07
7:53 pm
Aprea Therapeutics Inc. APRE HealthCap VII L.P.
HealthCap VII GP S.A.
10% Owner
266,667 $15 $4,000,005 2,366,104
(Indirect)
View
2019-10-07
Purchase
2019-10-07
7:40 pm
Aprea Therapeutics Inc. APRE Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
10% Owner
333,333 $15 $4,999,995 2,519,323
(Direct
Indirect)
View
2019-10-07
Purchase
2019-10-07
7:39 pm
Aprea Therapeutics Inc. APRE Versant V Luxco S.a r.l.
Versant Ventures V LLC
Versant Ventures V GP-GP (Canada) Inc.
Versant Ventures V (Canada) L.P.
Versant Venture Capital V (Canada) LP
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V L.P.
10% Owner
333,333 $15 $4,999,995 2,519,323
(Indirect
Direct)
View
2019-10-07
Purchase
2019-10-07
7:33 pm
Aprea Therapeutics Inc. APRE Christenson Johan
Director
266,667 $15 $4,000,005 2,366,104
(Indirect)
View
2019-10-07
Purchase
2019-10-07
7:25 pm
Aprea Therapeutics Inc. APRE Magni Guido
Director
6,500 $15 $97,500 6,500
(Direct)
View
2019-10-07
Purchase
2019-10-07
7:23 pm
Aprea Therapeutics Inc. APRE HENNEMAN JOHN B III
Director
5,000 $15 $75,000 18,407
(Direct)
View
2019-10-07
Purchase
2019-10-07
7:21 pm
Aprea Therapeutics Inc. APRE Korbel Gregory Alan
VP
500 $15 $7,500 64,322
(Direct)
View
2019-10-07
Purchase
2019-10-07
7:18 pm
Aprea Therapeutics Inc. APRE Attar Eyal C.
SVP Chief Medical Officer
400 $15 $6,000 77,630
(Indirect
Direct)
View
2019-10-07
Purchase
2019-10-07
7:15 pm
Aprea Therapeutics Inc. APRE Coiante Scott M
CFO
2,500 $15 $37,500 150,824
(Direct)
View
2019-10-07
Purchase
2019-10-07
7:15 pm
Aprea Therapeutics Inc. APRE SCHADE CHRISTIAN S
CEO
11,000 $15 $165,000 306,085
(Direct
Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2019-10-07
Conversion
2019-10-09
6:23 pm
N/A
N/A
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
DIEKMAN JOHN D
Schwab Andrew J.
PARMAR KUSH
10% Owner
1,913,910 $0 2,418,548
(Indirect)
View
2019-10-07
Conversion
2019-10-09
6:23 pm
N/A
N/A
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
DIEKMAN JOHN D
Schwab Andrew J.
PARMAR KUSH
10% Owner
79,746 $0 2,418,548
(Indirect)
View
2019-10-07
Conversion
2019-10-09
6:23 pm
N/A
N/A
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
DIEKMAN JOHN D
Schwab Andrew J.
PARMAR KUSH
10% Owner
492,475 $0 2,418,548
(Indirect)
View
2019-10-07
Conversion
2019-10-09
6:23 pm
N/A
N/A
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
DIEKMAN JOHN D
Schwab Andrew J.
PARMAR KUSH
10% Owner
20,519 $0 2,418,548
(Indirect)
View
2019-10-07
Conversion
2019-10-09
6:23 pm
N/A
N/A
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
DIEKMAN JOHN D
Schwab Andrew J.
PARMAR KUSH
10% Owner
1,913,910 $0 2,418,548
(Indirect)
View
2019-10-07
Conversion
2019-10-09
6:23 pm
N/A
N/A
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
DIEKMAN JOHN D
Schwab Andrew J.
PARMAR KUSH
10% Owner
79,746 $0 2,418,548
(Indirect)
View
2019-10-07
Conversion
2019-10-09
6:23 pm
N/A
N/A
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
DIEKMAN JOHN D
Schwab Andrew J.
PARMAR KUSH
10% Owner
492,475 $0 2,418,548
(Indirect)
View
2019-10-07
Conversion
2019-10-09
6:23 pm
N/A
N/A
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
DIEKMAN JOHN D
Schwab Andrew J.
PARMAR KUSH
10% Owner
20,519 $0 2,418,548
(Indirect)
View
2019-10-07
Conversion
2019-10-08
8:13 pm
N/A
N/A
Aprea Therapeutics Inc. APRE Redmile Group LLC
Green Jeremy
10% Owner
1,868,718 $0 2,268,718
(Indirect)
View
2019-10-07
Conversion
2019-10-08
8:13 pm
N/A
N/A
Aprea Therapeutics Inc. APRE Redmile Group LLC
Green Jeremy
10% Owner
1,164,674 $0 2,268,718
(Indirect)
View
2019-10-07
Conversion
2019-10-07
7:53 pm
N/A
N/A
Aprea Therapeutics Inc. APRE HealthCap VII L.P.
HealthCap VII GP S.A.
10% Owner
1,661,382 $0 2,366,104
(Indirect)
View
2019-10-07
Conversion
2019-10-07
7:53 pm
N/A
N/A
Aprea Therapeutics Inc. APRE HealthCap VII L.P.
HealthCap VII GP S.A.
10% Owner
427,496 $0 2,366,104
(Indirect)
View
2019-10-07
Conversion
2019-10-07
7:53 pm
N/A
N/A
Aprea Therapeutics Inc. APRE HealthCap VII L.P.
HealthCap VII GP S.A.
10% Owner
1,661,382 $0 2,366,104
(Indirect)
View
2019-10-07
Conversion
2019-10-07
7:53 pm
N/A
N/A
Aprea Therapeutics Inc. APRE HealthCap VII L.P.
HealthCap VII GP S.A.
10% Owner
427,496 $0 2,366,104
(Indirect)
View
2019-10-07
Conversion
2019-10-07
7:40 pm
N/A
N/A
Aprea Therapeutics Inc. APRE Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
10% Owner
1,993,658 $0 2,519,323
(Indirect)
View
2019-10-07
Conversion
2019-10-07
7:40 pm
N/A
N/A
Aprea Therapeutics Inc. APRE Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
10% Owner
512,995 $0 2,519,323
(Indirect)
View
2019-10-07
Conversion
2019-10-07
7:40 pm
N/A
N/A
Aprea Therapeutics Inc. APRE Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
10% Owner
1,993,658 $0 2,519,323
(Indirect)
View
2019-10-07
Conversion
2019-10-07
7:40 pm
N/A
N/A
Aprea Therapeutics Inc. APRE Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
10% Owner
512,995 $0 2,519,323
(Indirect)
View
2019-10-07
Conversion
2019-10-07
7:39 pm
N/A
N/A
Aprea Therapeutics Inc. APRE Versant V Luxco S.a r.l.
Versant Ventures V LLC
Versant Ventures V GP-GP (Canada) Inc.
Versant Ventures V (Canada) L.P.
Versant Venture Capital V (Canada) LP
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V L.P.
10% Owner
1,993,658 $0 2,519,323
(Direct)
View
2019-10-07
Conversion
2019-10-07
7:39 pm
N/A
N/A
Aprea Therapeutics Inc. APRE Versant V Luxco S.a r.l.
Versant Ventures V LLC
Versant Ventures V GP-GP (Canada) Inc.
Versant Ventures V (Canada) L.P.
Versant Venture Capital V (Canada) LP
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V L.P.
10% Owner
512,995 $0 2,519,323
(Direct)
View
2019-10-07
Conversion
2019-10-07
7:39 pm
N/A
N/A
Aprea Therapeutics Inc. APRE Versant V Luxco S.a r.l.
Versant Ventures V LLC
Versant Ventures V GP-GP (Canada) Inc.
Versant Ventures V (Canada) L.P.
Versant Venture Capital V (Canada) LP
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V L.P.
10% Owner
1,993,658 $0 2,519,323
(Direct)
View
2019-10-07
Conversion
2019-10-07
7:39 pm
N/A
N/A
Aprea Therapeutics Inc. APRE Versant V Luxco S.a r.l.
Versant Ventures V LLC
Versant Ventures V GP-GP (Canada) Inc.
Versant Ventures V (Canada) L.P.
Versant Venture Capital V (Canada) LP
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V L.P.
10% Owner
512,995 $0 2,519,323
(Direct)
View
2019-10-07
Conversion
2019-10-07
7:33 pm
N/A
N/A
Aprea Therapeutics Inc. APRE Christenson Johan
Director
1,661,382 $0 2,366,104
(Indirect)
View
2019-10-07
Conversion
2019-10-07
7:33 pm
N/A
N/A
Aprea Therapeutics Inc. APRE Christenson Johan
Director
427,496 $0 2,366,104
(Indirect)
View
2019-10-07
Conversion
2019-10-07
7:33 pm
N/A
N/A
Aprea Therapeutics Inc. APRE Christenson Johan
Director
1,661,382 $0 2,366,104
(Indirect)
View
2019-10-07
Conversion
2019-10-07
7:33 pm
N/A
N/A
Aprea Therapeutics Inc. APRE Christenson Johan
Director
427,496 $0 2,366,104
(Indirect)
View
2019-10-07
Exercise
2019-10-07
7:33 pm
N/A
N/A
Aprea Therapeutics Inc. APRE Seizinger Bernd R.
Director
263,970 $0.07 263,970
(Direct)
View
2019-10-07
Exercise
2019-10-07
7:33 pm
N/A
2025-09-04
Aprea Therapeutics Inc. APRE Seizinger Bernd R.
Director
263,970 $0.07 263,970
(Direct)
View
2019-10-07
Conversion
2019-10-07
7:33 pm
N/A
N/A
Aprea Therapeutics Inc. APRE KDev Investments AB
Karolinska Development AB
KCIF Co-Investment Fund KB
10% Owner
1,600,559 $0 2,444,837
(Indirect)
View
2019-10-07
Conversion
2019-10-07
7:33 pm
N/A
N/A
Aprea Therapeutics Inc. APRE KDev Investments AB
Karolinska Development AB
KCIF Co-Investment Fund KB
10% Owner
579,647 $0 2,444,837
(Indirect)
View
2019-10-07
Conversion
2019-10-07
7:33 pm
N/A
N/A
Aprea Therapeutics Inc. APRE KDev Investments AB
Karolinska Development AB
KCIF Co-Investment Fund KB
10% Owner
590,445 $0 2,444,837
(Indirect)
View
2019-10-07
Conversion
2019-10-07
7:33 pm
N/A
N/A
Aprea Therapeutics Inc. APRE KDev Investments AB
Karolinska Development AB
KCIF Co-Investment Fund KB
10% Owner
430,467 $0 2,444,837
(Indirect)
View
2019-10-07
Conversion
2019-10-07
7:29 pm
N/A
N/A
Aprea Therapeutics Inc. APRE ROCKLAGE SCOTT M
Director
1,913,910 $0 2,418,548
(Indirect)
View
2019-10-07
Conversion
2019-10-07
7:29 pm
N/A
N/A
Aprea Therapeutics Inc. APRE ROCKLAGE SCOTT M
Director
79,746 $0 2,418,548
(Indirect)
View
2019-10-07
Conversion
2019-10-07
7:29 pm
N/A
N/A
Aprea Therapeutics Inc. APRE ROCKLAGE SCOTT M
Director
492,475 $0 2,418,548
(Indirect)
View
2019-10-07
Conversion
2019-10-07
7:29 pm
N/A
N/A
Aprea Therapeutics Inc. APRE ROCKLAGE SCOTT M
Director
20,519 $0 2,418,548
(Indirect)
View
2019-10-07
Conversion
2019-10-07
7:29 pm
N/A
N/A
Aprea Therapeutics Inc. APRE ROCKLAGE SCOTT M
Director
1,913,910 $0 2,418,548
(Indirect)
View
2019-10-07
Conversion
2019-10-07
7:29 pm
N/A
N/A
Aprea Therapeutics Inc. APRE ROCKLAGE SCOTT M
Director
79,746 $0 2,418,548
(Indirect)
View
2019-10-07
Conversion
2019-10-07
7:29 pm
N/A
N/A
Aprea Therapeutics Inc. APRE ROCKLAGE SCOTT M
Director
492,475 $0 2,418,548
(Indirect)
View
2019-10-07
Conversion
2019-10-07
7:29 pm
N/A
N/A
Aprea Therapeutics Inc. APRE ROCKLAGE SCOTT M
Director
20,519 $0 2,418,548
(Indirect)
View
2019-10-07
Option Award
2019-10-07
7:23 pm
N/A
2029-10-02
Aprea Therapeutics Inc. APRE HENNEMAN JOHN B III
Director
18,407 $15 18,407
(Direct)
View
2019-10-07
Option Award
2019-10-07
7:21 pm
N/A
2029-10-02
Aprea Therapeutics Inc. APRE Korbel Gregory Alan
VP
64,322 $15 64,322
(Direct)
View
2019-10-07
Option Award
2019-10-07
7:19 pm
N/A
2029-10-02
Aprea Therapeutics Inc. APRE Abrahmsen Lars B.
SVP Chief Scientific Officer
77,630 $15 77,630
(Direct)
View
2019-10-07
Option Award
2019-10-07
7:18 pm
N/A
2029-10-02
Aprea Therapeutics Inc. APRE Attar Eyal C.
SVP Chief Medical Officer
77,630 $15 77,630
(Direct)
View
2019-10-07
Option Award
2019-10-07
7:15 pm
N/A
2029-10-02
Aprea Therapeutics Inc. APRE Coiante Scott M
CFO
150,824 $15 150,824
(Direct)
View
2019-10-07
Option Award
2019-10-07
7:15 pm
N/A
2029-10-02
Aprea Therapeutics Inc. APRE SCHADE CHRISTIAN S
CEO
306,085 $15 306,085
(Direct)
View